Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Podo

Showing results (61-70 of 75) with videos related to

Pageof 8
Sort By:
Magnetic Resonance Imaging|January 1, 1995
Quality assessment in in vivo NMR spectroscopy: III. Clinical test objects: design, construction, and solutionsM O Leach, D J Collins, S Keevil, et al.
Anticancer Research|July 1, 1993
Pentose phosphate pathway alterations in multi-drug resistant leukemic T-cells: 31P NMR and enzymatic studiesA Ferretti, L L Chen, M Di Vito, et al.
International Journal of Cancer|October 15, 1988
Tumor necrosis factor alpha induces early morphologic and metabolic alterations in Friend leukemia cell tumors and fibrosarcomas in miceE Proietti, F Belardelli, G Carpinelli, et al.
International Journal of Cancer|July 15, 1989
Interleukin-1 beta induces tumor necrosis and early morphologic and metabolic changes in transplantable mouse tumors. Similarities with the anti-tumor effects of tumor necrosis factor alpha or betaF Belardelli, E Proietti, V Ciolli, et al.
Biochemical Pharmacology|November 28, 1997
Intracellular metabolism of 3'-azido-3'-deoxythymidine (AZT): a nuclear magnetic resonance study on T-lymphoblastoid cell lines with different resistance to AZTM Di Vito, A Bozzi, A Ferretti, et al.
British Journal of Cancer|December 17, 2013
Monitoring response to cytostatic cisplatin in a HER2(+) ovary cancer model by MRI and in vitro and in vivo MR spectroscopyM E Pisanu, A Ricci, L Paris, et al.
British Journal of Cancer|November 28, 2013
Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancerA Granata, R Nicoletti, V Tinaglia, et al.
Biochimica Et Biophysica Acta|June 15, 1999
Biophysical and structural characterization of 1H-NMR-detectable mobile lipid domains in NIH-3T3 fibroblastsA Ferretti, A Knijn, E Iorio, et al.
Biochimica Et Biophysica Acta|May 9, 2001
1H NMR-visible mobile lipid domains correlate with cytoplasmic lipid bodies in apoptotic T-lymphoblastoid cellsM Di Vito, L Lenti, A Knijn, et al.
Technology and Health Care : Official Journal of the European Society for Engineering and Medicine|December 1, 1994
International workshop on standardization in clinical MRS measurements: proceedings and recommendationsM O Leach, D Arnold, T R Brown, et al.
Pageof 8

Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Magnetic Resonance Imaging|January 1, 1995
Quality assessment in in vivo NMR spectroscopy: III. Clinical test objects: design, construction, and solutionsM O Leach, D J Collins, S Keevil, et al.
Anticancer Research|July 1, 1993
Pentose phosphate pathway alterations in multi-drug resistant leukemic T-cells: 31P NMR and enzymatic studiesA Ferretti, L L Chen, M Di Vito, et al.
International Journal of Cancer|October 15, 1988
Tumor necrosis factor alpha induces early morphologic and metabolic alterations in Friend leukemia cell tumors and fibrosarcomas in miceE Proietti, F Belardelli, G Carpinelli, et al.
International Journal of Cancer|July 15, 1989
Interleukin-1 beta induces tumor necrosis and early morphologic and metabolic changes in transplantable mouse tumors. Similarities with the anti-tumor effects of tumor necrosis factor alpha or betaF Belardelli, E Proietti, V Ciolli, et al.
Biochemical Pharmacology|November 28, 1997
Intracellular metabolism of 3'-azido-3'-deoxythymidine (AZT): a nuclear magnetic resonance study on T-lymphoblastoid cell lines with different resistance to AZTM Di Vito, A Bozzi, A Ferretti, et al.
British Journal of Cancer|December 17, 2013
Monitoring response to cytostatic cisplatin in a HER2(+) ovary cancer model by MRI and in vitro and in vivo MR spectroscopyM E Pisanu, A Ricci, L Paris, et al.
British Journal of Cancer|November 28, 2013
Choline kinase-alpha by regulating cell aggressiveness and drug sensitivity is a potential druggable target for ovarian cancerA Granata, R Nicoletti, V Tinaglia, et al.
Biochimica Et Biophysica Acta|June 15, 1999
Biophysical and structural characterization of 1H-NMR-detectable mobile lipid domains in NIH-3T3 fibroblastsA Ferretti, A Knijn, E Iorio, et al.
Biochimica Et Biophysica Acta|May 9, 2001
1H NMR-visible mobile lipid domains correlate with cytoplasmic lipid bodies in apoptotic T-lymphoblastoid cellsM Di Vito, L Lenti, A Knijn, et al.
Technology and Health Care : Official Journal of the European Society for Engineering and Medicine|December 1, 1994
International workshop on standardization in clinical MRS measurements: proceedings and recommendationsM O Leach, D Arnold, T R Brown, et al.
Pageof 8